imatinib mesylate has been researched along with Monosomy in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chopra, A; Gogia, A; Jha, A; Kumar, R; Mallik, N | 1 |
| Barba, P; Bernal, T; Bethencourt, C; Brunet, S; Cervera, J; Del Potro, E; Feliu, E; Fernández-Abellán, P; González-Campos, J; Granada, I; Grande, C; Grau, J; Hernández-Rivas, JM; Montesinos, P; Moreno, MJ; Morgades, M; Motlló, C; Ribera, JM; Sarrà, J; Tormo, M | 1 |
| Bendit, I; de Alencar Fischer Chamone, D; de Mello Conchon, MR; Dias, L; Dorlhiac-Llacer, PE; Ferreira, P; Kumeda, C; Lima, W | 1 |
| Hackanson, B; Lübbert, M; Rückert, A | 1 |
| Corless, CL; Duensing, A; Fletcher, CD; Fletcher, JA; Heinrich, MC; Hornick, JL; Medeiros, F; Oliveira, AM | 1 |
| DellaValla, J; Martin, SE | 1 |
| Donti, E; Gozzetti, A; Ronconi, S; Spedicato, F; Valenti, AM; Zaccaria, A | 1 |
| Colomer, D; Espinet, B; Feliu, E; Granada, I; Grau, J; Juncà, J; Millá, F; Navarro, JT; Oriol, A; Ribera, JM | 1 |
| Anderson, B; Barcos, M; Kakati, S; Wetzler, M; Zeidan, A | 1 |
1 review(s) available for imatinib mesylate and Monosomy
| Article | Year |
|---|---|
Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).
Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Chromosome Deletion; Chromosomes, Human, Pair 7; Cytarabine; Disease Progression; Fatal Outcome; Humans; Imatinib Mesylate; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Leukocytosis; Male; Monosomy; Philadelphia Chromosome; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Selection, Genetic | 2009 |
8 other study(ies) available for imatinib mesylate and Monosomy
| Article | Year |
|---|---|
Development of myelodysplastic syndrome in a patient with chronic myelogenous leukemia treated with imatinib.
Topics: Antineoplastic Agents; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 20; Chromosomes, Human, Pair 7; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Monosomy; Myelodysplastic Syndromes | 2015 |
Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Protocols; Benzamides; Female; Humans; Imatinib Mesylate; Karyotype; Karyotyping; Male; Middle Aged; Monosomy; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prognosis; Pyrimidines; Remission Induction; Risk Adjustment; Young Adult | 2014 |
Emergence of abnormal clone with monsomy 7 in Philadelphia negative cells of CML patients treated with tyrosine kinase inhibitors.
Topics: Benzamides; Chromosomes, Human, Pair 7; Clone Cells; Dasatinib; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Monosomy; Myelodysplastic Syndromes; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Young Adult | 2009 |
KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications.
Topics: Adult; Aged; Benzamides; Chromosomes, Human, 13-15; DNA Mutational Analysis; Epithelial Cells; Exons; Female; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Immunoblotting; Immunohistochemistry; Karyotyping; Male; Middle Aged; Monosomy; Mutation, Missense; Oncogene Proteins; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Stromal Cells | 2004 |
Untreated essential thrombocythemia evolving to biphenotypic leukemia, Philadelphia chromosome positive with monosomy 7: response to imatinib and reduced-intensity allogeneic stem cell transplant.
Topics: Adult; Antineoplastic Agents; Benzamides; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Monosomy; Piperazines; Pyrimidines; Thrombocytosis; Transplantation, Homologous | 2005 |
Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia.
Topics: Adult; Aged; Aged, 80 and over; Aneuploidy; Antineoplastic Agents; Benzamides; Chromosome Aberrations; Chromosome Deletion; Clone Cells; Drug Resistance, Neoplasm; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Monosomy; Neoplastic Cells, Circulating; Philadelphia Chromosome; Piperazines; Prognosis; Pyrimidines; Remission Induction; Trisomy | 2007 |
Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.
Topics: Antineoplastic Agents; Benzamides; Chromosomes, Human, Pair 7; Disease Progression; Fatal Outcome; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Male; Middle Aged; Monosomy; Myelodysplastic Syndromes; Piperazines; Pyrimidines; Treatment Outcome | 2007 |
Monosomy 7 in t(9;22)-negative cells during nilotinib therapy in an imatinib-resistant chronic myeloid leukemia case.
Topics: Adult; Aneugens; Antineoplastic Agents; Benzamides; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 7; Chromosomes, Human, Pair 9; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Monosomy; Piperazines; Pyrimidines; Translocation, Genetic | 2007 |